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Abstract 
Isochromosomes are nonrandom chromosomal 
anomalies in acute lymphoblastic leukemia (ALL), 
but relatively few patients ALL and i(8)(q10) have 
been reported. In the majority of cases, i(8)(q10) was 
part of complex karyotypes, suggesting that it is a 
secondary chromosomal abnormality in ALL 
associated with clonal evolution. 
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Identity 
Partial karyotypes with isochchromosome i(8)(q10) (A). Fluorescence in situ hybridization with LSI MYC probe 
hybridizing to 8q24 (Vysis/Abott Molecular, US) showing end-to-end joining of homologous chromosomes 8 at 
the telomeres (B). It can be hypothesized that telomeric fusion of homologous chromosomes can promote 
creation of an unstable dicentric chromosome potentially causing an unbalanced translocation product. However, 
the precise consequences of telomere fusion events and their role in formation of isochromosomes remain 
unclear. 
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Clinics and pathology 
Disease 
Acute lymphoblastic leukemia 
Phenotype/cell stem origin 
Associated with B-lineage immunophenotype with 
exception of 1 chronic myeloid leukaemia  (CML) 
with lymphoid blast crisis of B-cell type who 
developed a secondary T-cell ALL (Dawson et al., 
1999) case and 2 biphenotypic leukemia (Sulak et 
al.,1990; Saikevich et al., 1991) patients. 
Epidemiology 
At least 40 reported cases (21 males, 19 
females aged 0 to 85 years; median age 17 
years) were described. Nearly half the cases 
were children: 2 female infants (O'Malley et 
al., 1988; Pui et al., 1991) and 12 pediatric 
cases aged 0 to 15 years (Pollak & Hagemeijer 
1987; Krance et al., 1992; Pui et al., 1992; Rafi 
et al., 2000; An et al., 2008; Suenobu et al., 
2010; Chapiro et al., 2011; Harrison et al., 
2014; Olsson et al., 2015; Yasuda et al.,  2016; 
Zhang et al., 2016) or young adults aged 17 to 
24 years old ( Mossafa et al., 1994; Tang et al., 
1998; Jarosova et al., 2000; Soriani et al., 
2011; Harrison et al., 2014; Safavi et al., 2015) 
(Table 1).
 
  Sex/Age Karyotype 
1 F/7 47,XX,del(7)(p?),i(8)(q10),add(9)(p21),ins(9;9)(p21;q12q22),add(14)(q?)  
2 F/0  
46,XX,ins(11;4)/46,idem,del(5)(q15q33)/46,idem,del(5),i(8)(q10)/46,idem,t(2;4)(q33;p16),del(5)/47,ide
m,+8/ 
3 M/85 77-87,XY,-X,-Y,del(5)(q23)x2,i(8)(q10)x2,add(22)(q13),inc        Bilineage or biphenotypic leukemia 
4 M/53 46,XY,+1,der(1;16)(q10;p10),i(8)(q10),t(9;22),-12,der(15)t(12;15)(q12;p11),i(17)(q10),+21 
5 F/0 50,XX,+X,+X,i(8)(q10),+10,-20,+21,i(21)(q10)x2,+mar  
6 M/63 
43,XY,t(1;9)(q?32;p?24),-2,der(3)t(3;12;17)(p?14;p?11;q?25),-5,i(8)(q10),-
12,der(17)t(3;12;17)       Bilineage or biphenotypic leukemia 
7 M/13  46,XY,i(8)(q10),t(12;17)(p13;q21) 
8 M/10  46,XY,i(7)(q10),t(9;22)(q34;q11)/48,idem,i(8)(q10),+i(8)(q10)x2  
9 M 49,XY,+4,+8,i(8)(q10)x2,t(9;22)(q34;q11),+der(22)t(9;22)  
10 F 46,XX,t(9;22)(q34;q11)/47,idem,+i(8)(q10)/47,idem,+8,i(8)(q10)x2 
11 F/60  46,XX,t(9;22)(q34;q11)/46,idem,i(8)(q10) 
12 M/44  46,XY,i(8)(q10),t(9;22)(q34;q11) 
13 F/24  46,XX,del(6)(q21q24),i(8)(q10) 
14 M 46,XY,t(14;18)(q32;q21)/46,XY,del(3)(p24),i(8)(q10),del(12)(p12) 
15 F/42  47,XX,dup(1)(q21q32),add(2)(p11),+7,i(8)(q10),t(8;22)(q24;q11)/47,idem,-dup(1),+trp(1)(q21q32) 
16 F/36  53,XX,+4,t(9;22)(q34;q11),i(8)(q10),+18,+19,+der(22)t(9;22)x2 
17 M/53 46,XY,t(9;22)(q34;q11)/45,XY,-7,i(8)(q10),ider(9)(q10)t(9;22),der(22)t(9;22) 
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18 M 48,XY,i(8)(q10),t(9;22)(q34;q11),+2mar  





46,Y,t(X;11),i(7)(q10),dup(8)(q21q22)/46,idem,i(8)(q10)/45,idem,-Y       T-cell ALL after chemotherapy 
for CML 




24 M/62 46,XY,del(1)(q32),i(8)(q10),-9,-10,der(22)t(9;22)(q34;q11),+2mar 
25 F/48 45,X,-X,add(1)(p36),-5,add(6)(q15),i(8)(q10),add(18)(p11)   
26 F/14  45,XX,i(8)(q10),dic(9;12)(p11;p11),der(17)t(?X;17)(?q12;?p11)  
27 F/13 46,XX,dic(9;20)(p11;q11),+21/46,idem,i(8)(q10)/46,idem,add(15)(p10) 
28 M/51 46,XY,i(8)(q10),t(9;22)(q34;q11),der(9)t(8;9)(q1?;p12)  
29 M  47,XY,i(8)(q10),+21c 
30 F/13  
45,XX,t(9;22)(q34;q11),add(10)(q22),-12,der(12)t(12;12)(p13;q13),i(17)(q10)/45,idem,i(8)(q10) 
46,X,-X,+1,t(2;16)(p10;q10),+8,-9,t(9;22),add(10),-12,der(12),-
13,i(17)(q10),+18,add(19)(p13),del(19)(q?),+21,-22,+mar/47,idem,+8       therapy for neuroblastoma 
31 M/17 48,XY,i(8)(q10),+i(8)(q10)x2,t(9;22)(q34;q11)/49,idem,+der(22)t(9;22) 




34 M 46,XY,-21,+r/46,idem,inv(11)(p15q13)/46,idem,i(8)(q10) 
35 F/19  
44,XX,i(8)(q10),-10,add(11)(q23),add(12)(p13),-14,add(14)(q32),add(15)(q25), +16,add(21)(q22),-
22,+mar 
1.Pollak & Hagemeijer 1987; 2.O'Malley et al., 1988; 3.Sulak et al.,1990; 4.Kageyama et al., 1991; 5.Pui et al., 
1991; 6.Saikevich et al., 1991; 7.Krance et al., 1992; 8.Pui et al., 1992; 9.Dewald et al., 1993; 10.Tuszynski et al., 
1993; 11-13.Mossafa et al., 1994; 14.Pirc-Danoewinata et al., 1995; 15.Martineau et al., 1996; 16-17.Rieder et al., 
1996; 18.Pabst et al., 1996; 19.Tang et al., 1998; 20.Dabaja et al., 1999; 21.Dawson et al., 1999; 22.Jarosova et 
al., 2000; 23.Rafi et al., 2000; 24.Rieder et al., 2003; 25.Strefford et al., 2007; 26-27.An et al., 2008; 28.Coyaud 
et al., 2010; 29.Kowalczyk et al., 2010; 30.Suenobu et al., 2010; 31.Soriani et al., 2011; 32.Chapiro et al., 2013; 
33-36.Harrison et al., 2014; 37.Olsson et al., 2015; 38.Safavi et al., 2015; 39.Yasuda et al., 2016; 40.Zhang et al., 
2016.  
 Abbreviations:  M, male; F, female. 
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Prognosis 
As it occurs rarely as a sole anomaly only in sporadic 
cases in ALL, thus the prognosis is uncertain; 
patients with favorable primary aberrations and 
i(8)(q10) may maintain favorable clinical outcome 
similar to patients with +8; its combination with 
unfavorable primary anomaly or complex anomalies 
may lead to the worst prognosis. 
Cytogenetics 
Cytogenetics morphological 
Sole abnormality in 3 (Kowalczyk et al., 2010; 
Olsson et al., 2015; Yasuda et al.,  2016) and in the 
stemline, but with other chromosomal changes in 4 
patients (Pirc-Danoewinata et al., 1995; Dabaja et 
al., 1999; Jarosova et al., 2000; Zhang et al., 2016). 
Double i(8)(q10) was detected in 5 cases (Sulak et 
al.,1990; Pui et al., 1992; Dewald et al., 1993; 
Tuszynski et al 1993; Soriani et al., 2011). Complex 
karyotypes, mainly with occurrence of primary 
anomalies in the remaining cases. Among them, the 
most common structural anomaly was 
t(9;22)(q34;q11) , found in 16 patients (Kageyama et 
al., 1991; Pui et al., 1992; Dewald et al., 1993; 
Tuszynski et al., 1993; Mossafa et al., 1994; Rieder 
et al., 1996; Pabst et al., 1996; Tang et al., 1998; Rafi 
et al., 2000; Rieder et al., 2003; Coyaud et al., 2010; 
Suenobu et al., 2010; Soriani et al., 2011; Safavi et 
al., 2015). 




Partial chromosome 8q gain resulting from an 
isochromosome i(8)(q10) is a nonrandom 
chromosomal anomaly in ALL. It occurs rarely as a 
sole anomaly and is mainly observed together with 
primary chromosome aberrations, most frequently 
with t(9;22)(q34;q11). Therefore, the occurrence of 
i(8)(q10) in ALL may signal clonal evolution, often 
associated with disease progression. The 
consequence of the formation of i(8)(q10) is gain of 
8q and loss of 8p, leading to imbalances in gene 
dosage. As trisomy 8 is among the most common 
secondary chromosome changes in hematological 
malignancies, it is likely that gain of 8q, but not the 
loss of 8p is important in leukemogenesis. In this 
regard it is interesting to note, that while extra 
chromosome 8 is a common clonal evolution marker 
for progression in CML, the occurrence of i(8)(q10) 
has been only rarely described during CML 
transformation. While differential diagnosis between 
blast transformation of CML and Ph1(+) ALL may 
be difficult, particularly in cases identified initially 
in blastic crisis, it is possible that i(8)(q10) is a 
specific secondary anomaly to t(9;22)(q34;q11) in a 
pre-B immunophenotype ALL. 
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